Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure

Journal of the American College of Cardiology

Volumn 43, Issue 4, 2004, Pages 635-641

  Logeart, Damien ^a   Thabut, Gabriel ^a   Jourdain, Patrick ^b   Chavelas, Christophe ^a   Beyne, Pascale ^a   Beauvais, Florence ^a   Bouvier, Erik ^a   Solal, Alain Cohen ^a  

^a BEAUJON HOSPITAL   (France)

^b CENTRE HOSPITALIER RENÉ DUBOS   (France)

Author keywords

B type natriuretic peptide; Congestive heart failure; Deceleration time of E wave; Hazard ratio; Heart failure; Left ventricle ventricular; Left ventricular ejection fraction; Receiver operating characteristic

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; B TYPE NATRIURETIC PEPTIDE ASSAY; BIOASSAY; BLOOD; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HIGH RISK PATIENT; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PREDICTION AND FORECASTING; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; RISK FACTOR; ROC CURVE; VALIDATION PROCESS;

EID: 1242295182     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2003.09.044     Document Type: Article

References (31)

1. Cowie M.R., Fox K.F., Wood D.A., et al. Hospitalization of patients with heart failure a population-based study . Eur Heart J. 23:2002;877-885.
2. Jong P., Vowinckel E., Liu P.P., et al. Prognosis and determinants of survival in patients newly hospitalized for heart failure. Arch Intern Med. 162:2002;1689-1694.
3. Philbin E.F., Rocco T.A., Lindenmuth N.W., Ulrich K., Jenkins P.L. Clinical outcomes in heart failure report from a community hospital-based registry . Am J Med. 107:1999;549-555.
4. Haldeman G.A., Croft J.B., Giles W.H., et al. Hospitalization of patients with heart failure national hospital discharge survey 1985-1995 . Am Heart J. 137:1999;352-360.
5. Krumholz H.M., Parent E.M., Tu N., et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 157:1997;99-104.
6. Rich M.W., Beckham V., Wittenberg C., et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 333:1995;1190-1195.
7. Stewart S., Pearson S., Horowitz J.D. Effects of a home-based intervention among patients with congestive heart failure discharged from acute hospital care. Arch Intern Med. 158:1998;1067-1072.
8. Krumholz H.M., Chen Y.T., Wang Y., Vaccarino V., Radford M.J., Horwitz R.I. Predictors of readmission among elderly survivors of admission with heart failure. Am Heart J. 139:2001;72-77.
9. Vanoverschelde J.L., Raphael D.A., Robert A.R., et al. Left ventricular filling in dilated cardiomyopathy relation to functional class and hemodynamics . J Am Coll Cardiol. 15:1990;1288-1295.
10. Pozzoli M., Traversi E., Cioffi G., et al. Loading manipulations improve the prognostic value of Doppler evaluation of mitral flow in patients with chronic heart failure. Circulation. 95:1997;1222-1230.
11. Whalley G.A., Doughty R.N., Gamble G.D., et al. Pseudonormal mitral filling pattern predicts re-admission in patients with congestive heart failure. J Am Coll Cardiol. 39:2002;1787-1795.
12. Maisel A.S., Krishnaswamy P., Nowak R.M., et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med. 347:2002;161-167.
13. Morrison K.L., Harrison A., Krishnaswamy P., et al. Utility of a rapid B-natriuretic peptide (BNP) assay in differentiating CHF from lung disease in patients presenting with dyspnea. J Am Coll Cardiol. 39:2002;202-209.
14. Logeart D., Saudubray C., Beyne P., et al. Comparative value of Doppler echocardiography and B-type natriuretic peptide assay in the etiologic diagnosis of acute dyspnea. J Am Coll Cardiol. 40:2002;1794-1800.
15. Arakawa N., Nakamura M., Aoki H., Hiramori K. Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations. J Am Coll Cardiol. 27:1996;1656-1661.
16. Richards A.M., Nicholls M.G., Yandle T.G., et al. Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction . Circulation. 97:1998;1921-1929.
17. Tsutamoto T., Wada A., Maeda K., et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction . Circulation. 96:1997;509-516.
18. Koglin J., Pehlivanli S., Schwaiblamir M., et al. Role of brain natriuretic peptide in risk stratification of patients with congestive heart failure. J Am Coll Cardiol. 38:2001;1934-1941.
19. Berger R., Huelsman M., Strecker K., et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation. 105:2002;2392-2397.
20. Senni M., Tribouilloy C.M., Rodeheffer R.J., et al. Congestive heart failure in the community a study of all incident cases in Olmsted County, Minnesota, in 1991 . Circulation. 98:1998;2282-2289.
21. Stevenson L.W., Perloff J.K. The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA. 261:1989;884-888.
22. Remes J., Miettinen H., Reunanen A., et al. Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J. 12:1991;315-321.
23. Xie G.Y., Berk M.R., Smith M.D., et al. Prognostic value of Doppler transmitral flow patterns in patients with congestive heart failure. J Am Coll Cardiol. 24:1994;132-139.
24. Giannuzzi P., Temporelli P.L., Bosimini E., et al. Independent and incremental prognostic value of Doppler-derived mitral deceleration time of early filling in both symptomatic and asymptomatic patients with left ventricular dysfunction. J Am Coll Cardiol. 28:1996;383-390.
25. Tabet J.Y., Logeart D., Geyer C., et al. Comparison of the prognostic value of left ventricular filling and peak oxygen uptake in patients with systolic heart failure. Eur Heart J. 21:2000;1864-1871.
26. Kazanegra R., Cheng V., Garcia A., et al. A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure a pilot study . J Card Failure. 7:2001;21-29.
27. Cheng V.L., Krishnaswamy P., Kazanegra R., et al. A rapid bedside test for B-type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure. J Am Coll Cardiol. 37:2001;386-391.
28. Maeda K., Takayoshi T., Wada A., et al. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J. 135:1998;825-832.
29. Nishimura R.A., Tajik A.J. Evaluation of diastolic filling of left ventricle in health and disease Doppler echocardiography is the clinician's Rosetta stone . J Am Coll Cardiol. 30:1997;8-18.
30. Appleton C.P., Firstenberg M.S., Garcia M.J., et al. The echo-Doppler evaluation of left ventricular diastolic function a current perspective . Cardiol Clin. 18:2000;513-546.
31. Troughton R.W., Frampton C.M., Yandle T.G., et al. Treatment of heart failure guided by plasma amino terminal brain natriuretic peptide (N-BNP) concentrations. Lancet. 355:2000;1126-1130.